[ad_1]
Lexaria Bioscience (CSE: LXX-OTCQX: LXRP) Proactive Investors Vancouver president John Docherty has joined Steve Darling to discuss a recent European double-blind clinical trial of hemp oil, fueled by cannabidiol by Lexaria.
Docherty explained to Proactive the parameters of the study and some impressive results. He also discussed 2019 and what this study and possibly others will achieve for the company and the licensing of the use of this technology.
Source link
